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1INTROUCTION
DIABETES MELLITUS
      Diabetes mellitus belongs to a type of metabolic disease
characterised   by hyperglycemia resulting from 1
? Defects in  insulin secretion
? Reduction in the effectiveness of secreted insulin
? Combination of the above
The raised blood sugar levels thus produces the characteristic
symptoms of
? polyuria
? polydipsia
? polyphagia .
Diabetes mellitus (DM)  mainly fall into  three  categories
2Type 1 DM
       It  is an autoimmune disease due to which the immune system of
ones own body attacks and destroys the insulin-producing cells of the
pancreas. It requires the  injection insulin. This was originally called as
insulin-dependent diabetes mellitus (IDDM) or juvenile diabetes.
Type 2 DM
          Resistance to insulin causes the cells  not to respond to the
secreted insulin along with a probable association with an absolute
insulin deficiency.  Earlier termed as adult-onset diabetes or  non
insulin-dependent diabetes mellitus (NIDDM).
The third category, gestational diabetes occurs in pregnancy,
who develop raised blood glucose levels during pregnancy in the
absence of previous history suggestive of raised glucose levels. It may
even precede development of type 2 DM. It disappears after delivery,
although it increases the chances of developing diabetes at a future date.
3Other forms of diabetes mellitus include
? congenital diabetes, associated with gene defects causing
insulin secretion defects,
? cystic fibrosis-related diabetes,
? steroid induced diabetes due to intake of high dose steroids
and other forms.
        With insulin becoming available, all categories of diabetes are
now treatable, with type 2 also having being cured with medications.
Both forms of the disease are chronic. Transplantation of the pancreas
has been tried as an alternative but success rates were low.
        Long term complications are usually high, usually manifest 10 to
20 years later, although it may be the presenting feature in a few
patients. Damage to the vascular system is the main reason for
complications.
4The risk of cardiovascular disease is greatly increased in a patient
with diabetes.
Macrovascular diseases associated are-
? ischemic heart disease
? stroke
? peripheral vascular disease.
Diabetes damages the small calibre vessels like capillaries.
Diabetic retinopathy,  causes formation of new blood vessels in
the retina, thus producing symptoms of decreased visual acuity and
sometimes potential blindness.
Diabetic nephropathy leads to chronic  scar formation in the
kidneys resulting in loss of proteins in the urine, culminating in chronic
kidney disease.
Diabetic neuropathy usually produces symptoms like numbness,
tingling and pain in the feet and also causes an increased damage to the
skin due to alteration in sensation.
5         Vascular disease affecting the legs together with neuropathy
results in an increases risk of developing diabetes-related foot
problems such as diabetic foot ulcers, which are chronic, making
treatment difficult ,ultimately leading to amputation of the affected part.
6OCULAR MANIFESTATIONS OF DIABETES MELLITUS
S.No. STRUCTURE MANIFESTATIONS
1. Lids Xanthelasma and recurrent stye or internal
hordeolum, chalazion
2 Conjunctiva Telangiectasia, sludging of the blood
in conjunctival vessels and subcon-
junctival
haemorrhage
3 Cornea Pigment dispersal at back of cornea,
decreased corneal sensations (due to
trigeminal neuropathy), punctate
kerotapathy, Descemet’s folds, higher
incidence of infective corneal ulcers
and delayed epithelial healing due to
abnormality in epithelial basement
membrane
4 Iris Rubeosis iridis (neovascularization)
5 Lens Snow-flake cataract in patients with
IDDM, posterior subcapsular cataract,
early onset and early maturation of senile
cataract
6 Vitreous Vitreous haemorrhage and fibre- vascular
proliferation secondary to diabetic
retinopathy Posterior vitreous detachment,
Asteroid bodies.
77 Retina Diabetic retinopathy and lipaemia
retinalis, Decreased contrast sensitivity
and colour vision.
8 Intraocular pressure Increased incidence of POAG,
neovascular glaucoma and hypotony in
diabetic ketoacidosis (due to increased
plasma bicarbonate levels)
9 Optic nerve Optic neuritis. Anterior ischaemic optic
neuropathy, optic atrophy
10 Extraocular
muscles
Ophthalmoplegia due to diabetic
neuropathy
11 Changes in
refraction
Hypermetropic shift in hypoglycemia,
myopic shift in hyperglycemia and
decreased accommodation
8DIABETIC RETINOPATHY
DR is a microangiopathy affecting the retinal precapillary
arterioles, capillaries, and venules.2 Loss of vision caused by DR,can be
prevented by timely diagnosis . One of the essential components of
diabetic care is to diagnose the earliest signs of DR, based on which,
early preventive and treatment methods can be implemented,thus
arresting the disease pregression and its sequelae.
The development of microvascular complications in diabetes
depends on the level of control of blood gloucose and blood pressure .
        Various modalities available for the treatment of severe non
proliferative and proliferative DR are
? laser photocoagulation
? ,anti-VEGF drugs
? vitrectomy.
Raised levels of glycosylated haemoglobin indicates that the prior
control of blood glucose levels were not satisfactory.2
9Thus leading on to
?  retinopathy
? cardiovascular disease
?  nephropathy .
It would be worthwhile to quote Sir. Stewart Duke Elder’s words
on diabetic retinopathy. “It is one of the major tragedies of
ophthalmology in the present generation, always common and rapidly
becoming still more  common, affecting the young as well as the aged,
predictable but not preventable and relatively untreatable, chronic and
progressive in its course and leading to blindness in a distressing % of
cases”. Bilateral involvement is a common feature in DR.
Facts on diabetic retinopathy
1. 85% to90% of cases of diabetes mellitus eventually develops DR
(WESDR).
2. Leading causes of blindness  in working age group world wide(3 .4)
3. Timely treatment can prevent  upto 60% to 70% of visual loss.
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Magnitude of problems in our country
o According to latest WHO report India has31.7 million
diabetic subjects currently.This number is expected to
increase to79.4 million  by 2030(5)
o The incidence of diabetes in Indians varies from that of
Europeans by
o Having a younger age of onset(6)
o Obesity being less (7)
o Stronger genetic association (8)
o These differences and the incresed prevalence of the
disease in India indicate the need for more diabetic based
studies .9
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REVIEW OF LITERATURE
1856 -  Eduard Jaeger - reported yellow coloured spots and
extravasations that permeated part or whole thickness of the
retina as part of DR changes10
1855 - Newly developed direct ophthalmoscope
1872  -  Edward Nettleship - cystoids degeneration of the macula
diabetes
 1876 - Wilhelm Manz - the proliferative changes, vitreous
haemorrhages and  tractional retinal detachments.
1899-1978  Charles Best - extracted insulin from the  Pancreas
1933 - Macherer - pars plana vitrectomy to treat vitreous
haemorrhages in PDR(11)
1943 - Arthur James Ballantyne - diabetic retinopathy -  a vascular
disease
1950 -  Gerhard Meyer-Schwickerath reported treatment of retinal
disorders with photocoagulation.12
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1953 - Poulsen- regression of PDR following post partum pituitary
necrosis (13)
1976  -  Patz – stabilization of macular oedema with argon laser
photocoagulation (14)
 1979 - The Diabetic Retinopathy Study Research Group - argon
laser panretinal photocoagulation (PRP) and  xenon arc
both decrease the severity of visual loss. 15
1985 - DRVS- early vitrectomy improves visual outcome.16
1993 -  DCCT-Intensive therapy sloes progression of DR17
1995 -  Early Treatment Diabetic Retinopathy study Research
Group (ETDRS) – Importance of panretinal
photocoagulation in severe NPDR and PDR 18
1998 - United kingdom prospective diabetes study (UKPDS)—
Strict control of  blood sugar  and blood pressure
management in prevention of long term complications19
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ANATOMY OF RETINA
Retina is the innermost tunic of the eyeball. It is a thin
,transparent and delicate membrane. It is the most highly developed
tissue of the eye. It appears purplish –red due to visual purple of rods.
light-sensitive tissue which lines the inner surface of the eye.
Retina is a light sensitive layer. Light falling upon the retina is
absorbed by the rods and cones which contain the photo sensitive
pigments. They  initiate photochemical changes which trigger a
sequence of various changes which initiate visual sensations.
Total retinal area 100000 mm sq. The retinal thickness  in the
macular area 400 micro metres and around the fovea 150 micro metres.
The retina thin out as it approaches to the equatorial region. This about
80 micro metres at ora serrata.
In retina there are  several layers of neurons, which are
interconnected through synapses. The photoreceptor cells  are the one
which are directly sensitive to light. They are  the rods and cones.
ANATOMY OF RETINA
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Anatomic Layers of the Retina
The layers of the retina from without inward are as follows:
? Retinal  pigment epithelium
? Layer of rods and cones
? External limiting membrane
? Outer nuclear layer
?  Outer plexiform layer
?  Inner nuclear layer
? Inner plexiform layer
? Ganglion cell layer
? The nerve fiber layer
? Internal  limiting membrane
SPECIALISED AREA OF NEURAL RETINA
Optic Disc
It is placed 3-4 mm on to the nasal  fovea. There is a central
depression which has variable size, is  called optic cup. The optic disc is
the location where the axons of the  ganglion cells  exceed the eye to
NORMAL FNUDUS
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form optic nerve. There are neither cones  nor rods in this area which
contributes  physiological blind spot. At this  optic disc  the major blood
vessels that supplies  the retina are entering into the retina.
Macula
Macula represents shallow concavity lying in thickened retina 4
m.m. away from the optic disc at the posterior pole and forming a
horizontal ellipse approximately 2 m.m. long 1.5 m.m. wide. In the
centre of the fovea there is small depression about 0.2 m.m. in diameter
called the foveola and it is at this that the greatest concentration of cones
occurs and where the focal point of entering rays of light is situated.
Fovea centralis
It is the centrally  depressed portion  of macula .It is about  1.85
mm  in diameter and 0.25mm in thickness..  They contain  cone cells
only each of  being which is connected to  one ganglion cell. Hence
contributes to  highest visual acuity .  The fovea centralis  represents
visual field  of 5 degrees.
BLOOD SUPPLY OF RETINA
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Blood supply
The outer one third of retina are supplied by choroidal plexus.
The inner two third of retina is supplied central retinal arteries.  Both are
branches of  the ophthalmic artery, which arises from internal carotid
artery.
 The retinal blood vessels provide nourishment to inner retinal
layers . Through diffusion from the choriocapillaris outer retinal layers
get nourishment  as  they are avascular . Despite this dual circulation to
the retina, functionally little overlap occurs, with the watershed zone at
the outer plexiform layer. The central retinal artery is an end artery that
has no significant anastomoses.
The retinal arteries and arterioles remain in the inner retina,  while
the inner nuclear layer contain only capillaries. The  venous drainage of
the retina usually follows the arterial supply of retina. The retinal veins
(mainly venules) are present in the inner retina, where they occasionally
interdigitate with their associated arteries.
Throughout the retina, the capillaries are arranged in laminar
meshworks.20
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     Retinal capillaries consist of two layers—
a. inner endothelial cells
b. outer layer of pericytes.
They are 5–6µm in diameter. The pericyte:endothelial ratio is 1:1,
which is relatively high compared with elsewhere in the central nervous
system or body in general. The capillary basement membrane  lies
inbetween endothelial cells and  pericytes .It is much thinner than the
basement membrane that covers the two types of cells, which probably
allows increased communications between the cells. The retinal
capillary endothelial cells are the major component of the blood-retinal
barrier. The retinal pericytes appear to be involved directly in the local
control of retinal blood flow and may affect endothelial cell proliferation
as well.
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EPIDEMIOLOGY
Diabetic Retinopathy is one of the leading cause of blindness in
both developed and developing countries. With the increase in incidence
of diabetes in India, diabetic retinopathy has become more prevalent and
is the sixth cause for blindness in our country. It is an important micro
vascular complication in both type I and type II diabetes.
Demographic risk factors
? Age group
? General
Systemic risk factors
1. Longer duration of diabetes 21,22,23,24
2. Severity of diabetes24,25
3. High systolic Bp 26,27
4. Pregnancy28
5. Patients on insulin treatment
19
6. Nephropathy
7. Hyperlipidaemia29,30
8. Smoking
9. Anaemia33,34.35
10. Alcoholism31,32
Ocular factors
? In glaucoma there is reduced metabolic activity and
reduced vascular perfusion.This ultimately protects from
development of DR.
? Unilateral carotid artery stenosis  protects the ipsilaeral eye
from development of DR..
? High myopes with choroidal degeneration patients are
protective  against DR due to reduced retinal metabolism.
? Cataract  removal exaggerate the progression of NPDR and
already existing DME and lead onto  the development of
rubeosis.36,37
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PATHOGENESIS OF DIABETIC RETINOPATHY
Diabetic retinopathy essentially is a microangiopathy affecting
mainly the small caliber retinal vessels (i.e) precapillary arterioles and
venules eventually resulting in either
1. Microvascular occlusion that causes hypoxia and development
of new vessels.
2. Microvascular leakages resulting macular oedema
A number of factors at the molecular,cellular,biochemical and
ulrastructural levels are implicated in the pathogenesis.
Hyperglycaemia induces these changes due to combination of
factor including biochemical,haemodynamic and paracrine factors
producing structural changes in the vessels including
    1. Pericytes degeneration
    2. Basement membrane thickening
    3. Endothelial cell proliferation
21
               Hyperglycaemia induced alternation
 Biochemical                Haemodynamic              paracrine
BIOCHEMICAL         ALTERATION
There  are  several  biochemical mechanisms  which  include
? Non –enzymatic glycation
? Polyol pathway
? protein kinase C activation
? oxidative stress
22
BIOCHEMICAL ALTERATION
1. Non enzymatic
Glycosylation and
AGE production
2. Increased
 polyol
pathway  flux
Endothelial
Apoptosis
VEGF
Production
Basement
membrane
thickening
3. Protein kinase
C activation
Induces /
mediates
action of VEGF
4. Oxidative Stress Oxygrn free
Radical demages
Endothelial cells
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HAEMODYNAMIC ALTERATIONS
Altered blood flow
The earliest retinovascular change seen in diabetic retinopathy is
vasodilatation due to abnormal tissue oxygenation.
 Thickening of basement membrane associated with pericyte loss
are the initial changes that occur in DR .The contractile properties
possed by the pericytes allows changes in the  lumen of the blood
vessels, thus    regulating  blood flow.
The changes in the vessel wall induce hypoxia. This induces
functional changes inthe retinal vasculature resuling in a change of
retinal tissue blood flow pattern. There occurs a hyperperfusion in
retinal circulation of diabetic patients  which leads to stress damage to
the vessel wall.At the capillary level there is increased viscosity of
blood,increased platelet aggregation which lead to further capillary
occlusion .
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Haemodynamic alteration
    Altered blood flow                              Hypercoagulable state
    Vasodilatation
PARACINE FACTORS
 Pathological abnormal neovascularization in patients with
diabetes results due to imbalance between the the positive regulators/
pro-angiogenic and negative regulators/ anti-angiogenic factors.
Platelet abnormalities
1.Increased fragility&
Adhesiveness
2.Increased
endoperoxidases
&thromboxane A2
3.Decreased thromboxane
4.Decreased prostocyclin
RBC abnormalities
1.Decreased ability of RBCs
to release oxygen
2.Decreased deformablily
3.Ingreased formation of
large aggregates
4.Increased whole blood
Viscosity
5. Increased Adhesiveness
to the endothelial cells
Leucocyte
Abnormalities
1.Increased  Leukocyte
adhesions
causing endothelial
injury,VEGF
release&opening of tight
junctions
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                                            Paracrine factors
 Pro-angiogenic factors                                 Anti-angiogenic factors
1. Vascular endothelial growth factor(VEGF),       1.Endostatin
2. platelet derived growth factor(PDGF),                  2.Angiostatin
3. hepatocyte growth factor(HGF),                        3.Pigment endothelium
4. erythropoietin,                                                                     derived factor
5. leptin, angiogenin,                                                  4.Genistein
6. insulin growth factor 1&2,                                     5.Thrombopondin 1
7. intracellular adhesion molecule 1 (ICAM1),     6. Platelet factor 4
8.  angiotension 2,
9. angiotensin converting enzyme,
MECHANISM FOR DIABETIC MACULAR OEDEMA
1. Hyperglycaemia causes breakdown of  blood-retina barrier by
? Increased pericelullar permeablility of vascular
endothelium
? Loss of endothelial cells layer injury  due  to cell
destruction
? Increased transcellular transport   through the endothelium
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2. Increased   blood flow   along with increased  hydrostatic pressure
in the capillaries and venules are due to less resistance offered by
the dilated retinal arterioles . This causes  the fluid to move out of
the vascular compartment as per Starling’s law
3.  The cellular structure of retinal capillaries consists of endothelial
cells and pericytes with one to one ratio.Uncontrolled diabetes
causes    loss of pericytes resulting in saccular out pouching of the
capillary wall clinically seen as microaneurysms,which tends to
leak resulting in retinal edema.
4  Raised   leukostasis  in the retina  affects  endothelial function
along with  perfusion of retina and vascular permeability in
diabetic patients which lead to development of DR.
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MECHANISM FOR RETINAL NEOVASCULARIZATION
1. Astrocyte precursors form a meshwork from optic disc to retinal
periphey that acts as a template for glial fibres for new vessels
2. New vessel follow the pre existing meshwork and tips of growing
vessels extend along the processes of astrocytes that secrete
VEGF and other angiogenic factors
3. The activated endothelial cells migrates and proliferate resulting
in the formation of solid endothelial stumps into the stroma.
4. Recanalisation of the stumps results in the formation of capillary
tubes with deposition of new basement menbrane and tightenig of
endothelial junctions.
MILD  NPDR
MODERATE NPDR
28
CLASSIFICATION
The most widely used classification is the ETDRS (The Early
Treatment Diabetic Retinopathy Study) Classification .
  It gives better understanding of the progression and management
of the condition.
ETDRS Classification
I. NPDR (Non – Proliferative Diabetic Retinopathy)
Retinal hemorrhages, exudates and venous abnormalities are the
hallmarks of NPDR which are classified as below :
a. Mild NPDR :
At least one microaneurysm
b. Moderate NPDR :
> Soft exudates, venous bleeding & IRMAS (Intraretinal
microvascular abnormalities)
SEVERE NPDR
NVE
NVD
EARLY PDR WITH VH
PDR WITH PRE RETINAL HAEMORRAGE
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c. Severe NPDR :
Presence of either of the following
i) Hemorrhages and microaneurysm in all 4 quadrants.
ii) Venous bleeding in 2 or > quadrant
iii) IRMA in at least 1 quadrant.
d. Very Severe NPDR :
Presence of either 2 or more of the criteria for severe NPDR.
II. PDR (Proliferative Diabetic Retinopathy)
It  is  composed  of  NVD  (New  Vessels  on  Disc)  or  NVE  (New
Vessels elsewhere), Vitreous or Pre-Retinal Hemorrhages and
Fibrovascular  proliferation.
1. Early PDR :
New Vessels on Disc or elsewhere
2. High risk PDR :
 i) NVD > 1/3 – 1/2 disc area
 ii) NVD & vitreous or pre-retinal hemorrhages
 iii) NVE > ½ disc area and vitreous or pre-retinal hemorrhages.
ADVANCED DIABETIC EYE DISEASE
CSME
30
3.  Advanced PDR :
Extensive vitreous hemorrhages precluding grading. RD in the
macula or Phthisis Bulbi or Enucleation secondary to a complication
of DR.
CSME (Clinically Significant Macular Edema)
1. Retinal thickening  within 500 micrometers of the centre of the
macula.
2. Exudates within 500 u from centre of macula along with retinal
thickening.
3. Retinal thickening 1 disc area or larger in size,any part of it
located within 1 disc diameter from the centre of macula.
DIABETIC MACULOPATHY
Hammersmith Classification :
This classification is based upon anatomical & Pathological
changes.
Type 1 : Exudate rings, microvascular lesions & focal fluorescein
leakage.
CIRCINATE RETINOPATHY
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Type 2 : Exudate plaques, increasing retinal hemorrhages and
capillary loss.
Type 3 : Extensive central ischemia & edema, few or no exudates.
II. Selgelman’s Classification :
Stage 1 :  Back ground maculopathy
Stage 2 : Focal leakage on fluorescein angiogram
Stage 3 : Diffuse leakage on fluorescein angigram
Stage 4 : Cystoid degeneration of the macula.
III. ETDRS  Classification :
1. Clinically Significant Macular Edema (CSME)
2. Ischemic Maculopathy
3. CME
4. Macular edema other than CSME
32
GRADING OF DIABETIC RETINOPATHY
International Clinical Diabetic retinopathy severity scale
Proposed disease severity level findings observable on dilated
ophthalmoscopy;
Proposed disease
severity level
Findings on dilated ophthalmoscopy
No apparent retinopathy No abnormalities
Mild Non proliferative
diabetic retinopathy
Microaneursms only
Moderate Non proliferative
diabetic retinopathy
More than just microaneursms but less
than severe non-proliferative diabetic
retinopathy.
Severe Non proliferative
diabetic retinopathy.
Any of the following more than 20
intraretinal hemorrhages in each of 4
quadrants; definite venous beading in 2+
quadrants; prominent intrarentinal
microvascular abnormalities in 1+
quadrant and no signs of proliferative
retinopathy.
Proliferative diabetic
retinopathy
One or more of the following
neovascularization, vitreous/ preretinal
hemorrhage.,
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Proposed disease severity level findings observable on dilated
ophthalmoscopy
Diabetic macular edema apperently absent. No apparent retinal
thickening or hard exudates in posterior pole.
If diabetic macular edema is present, it can be categorized as follows:
Diabetic macular edema
present
Mild diabetic macular edema : some
retinal thickening or hard exudates in
posterior pole but distant from the
center of the macula
Moderate diabetic macular edema:
retinal thickening or hard exudates
approaching the center of the macula
but not invovling the center.
Severe diabetic macular edema :
retinal thickening or hard exudates
involving the center of the macula
34
CLINICAL FEATURES
Microaneurysms
The first clinical manifestation of diabetic retinopathy is
MICROANEURYSM which are nothing but capillary outpouchings due
to loss of pericytes. It is seen as tiny red dots initially occuring temporal
to fovea. The diameter varies from 12 to 100 microns..It tend to be the
earliest sign of DR. Rupture of microaneurysm results in haemorrhages
which can be either blot or flame shaped. Majority of microaneurysm
occurs in the posterior pole and adjacent to the area of capillary
nonperfusion.
Dot and blot hemorrhages
 If microaneurysms rupture in the middle layers of the retina i.e at
the inner nuclear and outer plexiform layers, dot and blot haemorrhage
occur which can mimic microaneurysm if they are small and only FFA
can differentiate a such haemoorhage from a microaneurysm.
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Flame-shaped haemorrhages
These are nothing but splinter haemorrhages that occur in the
larger superficial precapillary arterioles of the  nerve fibre layer.
 Hard exudates
 Hard exudates are extracellular accumulation of lipids from the
leaking vessels in the OPL of the retina.They are composed of
lipoproteins and lipid filled macrophages.
Hard exudates are waxy yellow lesions with relatively distinct
margins,occuring as clumps or rings surrounding the leaking
microaneurysms most commonly at the posterior pole.
Cotton-wool spots
Capillary nonperfusion results in impaired axoplasmic flow and
accumulation of neuronal debris within the nerve fibre layer. These
accumulations are seen as cotton wool spots / soft exudates.
CWS are small, whitish fluffy superficial lesions obscuring
underlying blood vessels. They are clinically evident in post equatorial
region of retina.
36
 Venous changes
Capillary non perfusion and resulting retinal ischemia can lead on
to various venous changes like venous dilatation,venous loops and
venous beading which frequently occurs adjacent to areas of non
perfusion. Such changes corelates with the likelihood  of  progression to
PDR.
Intra retinal micro vascular abnormalities
They are fine irregular red intraretinal lines that run from
arterioles to venules without crossing major blood vessels.
Intraretinal microvascular abnormalities are arteriolar-venular
shunts that run from arterioles to venules bypassing capillary bed.
 IRMA is often seen adjacent to areas of marked capillary
hypoperfusion.
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Diabetic macular edema
Defective vision in diabetic patients is mainly due to macular
oedema. It has the following features
1. Thickening of macula
2. Blurring of underlying choroidal vascular pattern.
3. Loss of FR
4. Cystoid spaces
5.  Circinate retinopathy
Nonproliferative diabetic retinopathy
Occurence of at least 1 microaneurysm indicates mild NPDR. It
reflects structural changes in the retina caused by the physiological and
anatomical effects of diabetes.
 Microaneurysms, hard exudates and superficial and deep
haemorrhages occurs in moderate non proliferative diabetic retinopathy.
Cotton wool spots,venous changes and intraretinal microvascular
abnormalities  occur less frequently than with severe NPDR.
Advancement of severe NPDR leads to increased retinal ischemia
which can progress on to proliferative diabetic retinopathy,
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Severe NPDR (4-2-1) is characterized by haemorrhages and
microaneurysms in 4 quadrants, with venous beading in at least 2
quadrants and IRMA in at least 1 quadrant.
Proliferative diabetic retinopathy
PDR is characterised by the presence of neovascularisation
occuring near the disc or elsewhere accordingly they are named as
NVD  - neovascularisation on or within one disc diameter of the
ONH.
NVE - neovascularisation located further away from the disc.
39
CLINICAL EVALUATION
I. Visual Acuity
Loss of vision mainly depends on the involvement of the macula.
II. Color Perimetry
Field charting by perimetry may reveal scotomas corresponding
to areas of involvement in the fundus.
III. Color Vision
The most common defect observed is blue yellow. In diabetes the
sensitivity of blue cones are depressed. These defects are best detected
by Fransworth Munsell 100 hue test.
IV. Sterescopic Indirect Ophthalmoscope
This technique is of special importance because it allows to
integrate the view of the entire retina.
V. Slit Lamp Biomicroscope
It is done with
? 90D
40
? 78D
? Hruby lens
By combining these maneuvers, it is possible to see virtually the
entire retina.
VI. Direct Ophthalmoscopy
Though the area of field observed is smaller, increased
magnification obtained with this method allows detailed examination of
the various details of the fundus.
VII. Threshold Amster Grid Testing
This is a rapid, sensitive and high yield means of assessing the
central fields in patents with diabetic retinopathy.
VIII. Photo Stress Test
After images and central scotomas persist after a long time. This
explained the prolonged re-adaptation times in photo stress test in the
affected eye.
FFA OF NORMAL FUNDUS
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IX. Electrophysiology
i) Electro Retinography:
Early stages of diabetic retinopathy may reveal abnormalities of
oscillatory potential in the ascending limit of the ‘b wave’. Delay of
implicit time occurs as the macular edema progresses. (Brensick et al,
1984)
ii) Electro Oculography:
This test may reveal abnormal light to dark ratio (Arden’s ratio)
iii) Visually Evoked Responses:
The macular disease with edema, the VER shows amplitude
reduction depending on the reduced visual acuity with no change in
latency.
X. Fluorescein Angiography
This is one of the mandatory investigations needed in diabetic
retinopathy for :
? Confirmation of the diagnosis
LEAKAGE OF DYE IN FFA
FFA IN MACULAR EDEMA
OCT
NORMAL   OCT   PICTURE
OCT  PICTURE  OF  CSME
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? Documentation of the various lesion
? Deciding about the management
? Followup
XI .Optical coherence tomography (OCT).
It is a non invasive non contact procedure, mainly done in case of
macular edema to assess the severity and progression of disease.
XII. Heidelberg Retina Tomograph (HRT)
XIII.Retinal Thickness Analyzer (RTA)
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MANAGEMENT
Various treatment options available for DR  includes
1. Medical management
2. Lasers
3. Surgical
Medical management- includes
? Inhibitors of VEGF
? Aspirin
? Antioxidants
? Protein kinase  C inhibitors
? Somatostatin
? Cyclooxygenase -2 inhibitors
? Statins
? Aldose reductase inhibitor
? Enzymatic vitreolysis
Treatment depends largely on the stage of presentation of DR :
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EARLY NON PROLIFERATIVE  DIABETIC RETINOPATHY
Mild/moderate NPDR –
? No treatment
? In these stages further progression can be slowed by good
glycemic control.
? Control associated risk factors
 Advanced diabetic retinopathy
       Laser Photocoagulation for Diabetic Retinopathy
The rationale behind using Lasers is that
? PRP destroyes the hypoxic retina, so no angiogenic factors
are produced , thus reducing the rate of neovascularisation.
? PRP  also  allows  increased   oxygen   diffusion  from  the
choroid eliminating hypoxic status and thus reduces the
production of angiogenic factors and neovascularisation.
? Lasers uses heat to destroy or seal  an abnormal blood vessel
which leaks.
POST PRP FUNDUS
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? It can be done as an OP procedure under topical /local
anaesthesia.
LASERS
Various lasers used are
? Argon green
? Argon blue green
? Krypton red
? Frequency doubled Ndyag laser
? Micropulse diode laser.
LASER TREATMENT FOR CSME:
1.Focal laser :
? It is given 500 to 1000 micrometers from the centre of the
macula.
? Spot size – 50 to 100 micrometers
? Exposure time – 0.1 sec
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        2.Grid laser :
? It is given 500 micrometers from the centre of the
macula and 500 micrometers from the temporal margin
of optic disc.
? Spot size – 100 microns
? Exposure time – 0.1 sec
? Light intensity – minimal.
TREATMENT OF OTHER FORMS OF MACULOPATHY :
1.  LASERS
? Argon green
? Argon blue green
? Krypton red
? Frequency doubled Nd-yag
? Micropulse diode laser.
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2.   ANTI VEGF  AGENTS:
? Bevacizumab
? Ranibizumab
? Pegaptinib
3. STEROID
Triamcinolone given as intravitreal injections-
4. PARS PLANA VITRECTOMY
TREATMENT OF PROLIFERATIVE DIABETIC
RETINOPATHY
Panretinal photocoagulation
Panretinal photocoagulation (PRP) implies application of  laser
burns throughout the retina except  macular area. It can be given either
through  slit lamp,IDO or an EndoProbe.
PROCEDURE :
Intensity – moderate intensity
Spot size – 200 to 500 microns placed 1 spot size apart.
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 Start in a circumferential fashion at 500 µm from the disc and 2
DD from the fovea  thus avoiding the central retina and continue
peripherally.
 It can be given in 2 to 3 sessions and a total of 1200-1600 burns
can be given.
       In cases where macular oedema and PDR coexist, laser treatment
for the macular oedema are performed first,  then for PDR, the PRP is
spread over 3 to 4 sessions.
ANTI –VEGF AGENTS
Anti-VEGF agents like bevacizumab/ranibizumab/pegaptanib can
be administered via an intra-vitreal injection,  under sterile conditions
under topical  anaesthesia.
PARS PLANA VITRECTOMY
It is indicated in
? Severe persistent  vitreous haemorrhage
? Premacular subhyaloid haemorrhage
? tractional retinal detachment,
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? combined tractional and rhegmatogenous retinal
detachment.
CRYOTHERAPY
? The rationale behind using cryotherapy is that it creates an aseptic
chorioretinal adhesion so that oxygen supply to the retina is
increased.
? It is mainly used in presence of opaque media where  lasers
cannot be used
Complications of  Diabetic  Retinopathy
1. Retinal Detachment
 Separation of RPE and neuro sensory retina causes retinal
detachment.
Condensation and contraction of the vitreous  due to haemorrhage
and fibrosis leads to tractional retinal detachment in cases of PDR.
Ultimately it can result in combined  rhegmatogenous and tractional
retinal detachment.
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2. Rubeosis iridis and rubeotic glaucoma
In PDR severe retinal ischemia results in neovascularisation of
iris causing neovascular glaucoma. Later this can cause fibrovascular
proliferation at the angle causing closure of the angle resulting in angle
closure glaucoma.
3. Cataract
? Juvenile diabetic patients are prone to the development of
snow-flake cataract.
? Senile cataract occurs earlier in diabetic patients.
? In patients with uncontrolled diabetes and fluctuating blood
sugar levels, changes in fluid electrolyte balance can lead to
osmotic reversible cataract.
4. Glaucoma
Glaucoma occurs due to raised intraocular pressure and it can be
either  primary or secondary. Primary open angle glaucoma with loss of
visual field occurs commonly in diabetic patients. Secondary glaucoma
particularly rubeotic glaucoma develops in patients with PDR.
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5. Other ocular pathology in diabetes
? corneal epitheliopathy
? delayed  epithelial wound healing  following ocular
surgery.
Suggested Timetables For Detailed Ophthalmologic Examination of
Diabetic Patients
Age of Onset of DM
Recommended Time
of First Eye
Examination
Routine Minimum
Follow-up
0 – 30 Within five years of
Diagnosis
Annually
31 or Older Upon Diagnosis Annually
Pregnancy Before conception or
Early in first trimester
Every 3 months or at
the discretion of the
ophthalmologist
(preferred Practice Patterns Committee, AAO 2003)
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Suggested Timetables For Follow-up in Diabetic Retinopathy
Patients
Retinal Abnormality Suggested Follow-up
Normal or rare micro
aneurysms
Annually
Mild NPDR Every 9 months
Moderate NPDR Every 6 months
Severe NPDR Every2- 4 Months
CSME Every 2-4months (Consider laser
therapy)
PDR Every 2-3months (Consider laser
therapy)
(preferred Practice Patterns Committee, AAO 2003)
PART-II
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AIM  OF THE STUDY
 The aim of my  study was to find the incidence of retinopathy
changes, in newly detected DM type II. 200 eyes of 100 patients
attending the ophthalmology outpatient department of the Stanley
Medical College, Hospital, Chennai  between the period from July 2010
to November 2012 were studied.
       Special emphasis was laid in studying the following aspects;
? Age
? Sex incidence
? Presence of DR
? Staging of DR
? Presentation of complications
? Associated co morbid conditions
The results thus   obtained were analysed and tabulated.
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Inclusion criteria:
1. Age  group  between  30-60  years.
2. Both  male  and  female  patients
Exclusion criteria:
1. Type I diabetes mellitus
2. Chronic renal failure
3.   Pregnant women
4. Opaque media
Materials and Methods
           From  July 2010 to November 2012 100 patients who  were
diagnosed as new case of DM type II was taken up in this study.
Diagonostic  Crieteria
? Fasting  blood  sugar>126mg/dl
?  2 hrs  post prandial blood sugar >200mg / dl.
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Importance of fundus evaluation was  explained to the patients.
Evaluation procedure was explained  in patients’ own language and an
informed consent was obtained
After obtaining consent, history was elicited and systemic
examination done.
The following  evaluation was done:
1. Relevant ocular history
2. Best corrected visual acuity
3.  Slit lamp examination for  anterior segment
4. Posterior segment evaluation done using indirect
ophthalmoscope,slit lamp biomicroscopy  with  90D and
diabetic retinopathy /maculopathy was  graded using
ETDRS system.
5. Intraocular pressure measured with Goldmann
applanation tonometer.
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6. Gonioscopy
7. Visual field analysis.In selected  cases octopus automated
perimetry is done.
8. Fundus fluorescein angiography for selective cases.
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OBSERVATION
SEX DISTRIBUTION
           Sex No. of patients Percentage
Male             136 68%
Female             64 32%
    The ratio of male to female patients in our study was 2.1:1
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AGE DISTRIBUTION
Age No. of patients Percentage
30-40 yrs 61 30.5%
41-50 yrs 85 42.5%
51-60 yrs 54 27%
In this study, patients in the age group of 40 to 50 years were
predominantly affected(42.5%).
Least incidence was seen in  patients in the age group  between 50
to 60 years, because they had undergone previous blood sugar
evaluations for various purposes, hence their diabetic status detected
earlier.
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PREVALANCE OF DIABETIC RETINOPATHY
No. of Patients %
DR 32 16
NAD 168 84
Among the 200 patients evaluated 32 were diagnosed to have DR
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FAMILY HISTORY OF DIABETES MELLITUS
Family History No. of patients Percentage
Positive 12 12
Negative 88 88
Positive, 12
Negative, 8
8
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ASSOCIATED RISK FACTORS FOR THE DEVELOPMENT OF
DIABETIC RETINOPATHY
Associated risk factors No of patients Percentage
Smoking 15 7.5%
Alcoholism 7 3.5%
Anaemia 8 4%
Smoking+alcoholism 12 6%
Smoking+alcoholism+anaemia 24 12%
no risk factors 134 67%
Various risk factors involved in the development of retinopathy
includes smoking, alcohol  and anaemia.
24 patients had all the three and they had various stages of DR
including PDR.
15 7 8 12 24
134
No of patients
Smoking
Alcoholism
Anaemia
Smoking+alcoholism
Smoking+alcoholism+ana
emia
no risk factors
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INCIDENCE OF POAG
IOP No of patients Percentage
Normal IOP 194 97%
?IOP 6 3%
Among  the 200 patients, 6 of them    had raised intraocular
pressure above the normal level.
On gonioscopic examination with  Goldman single mirror lens the
angles were open.
normal
?IOP
No of patients
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LATERALITY
Laterality No. of patients Percentage
RE Affected 4 2%
LE Affected 4 2%
BE Affected 24 12%
NAD 168 84%
         In this study 12% of  patients had bilateral DR, though the severity
was asymmetrical in some patients.
        4% of patients had unilateral involvement.
0 50 100 150 200
RE Affected
LE Affected
BE Affected
NAD
No. of  Patients
RE Affected
LE Affected
BE Affected
NAD
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    V/A ON PRESENTATION
V/A on presentation No. of eyes Percentage
6/6 184 46%
6/9 -   6/18 174 43.5%
6/24 - 6/60 42 10.5%
<6/60 - -
HM - -
CFCF - -
On evaluating the visual acuity of patients on first presentation
majority  of them (46%)had visual  acuity of 6/6.
43.5% of patients had  visual acuity between 6/9 and 6/18.
10.5% patients had visual acuity between 6/24 and 6/60.
 The reduction in vision is due to various other causes which
includes
? Cataract
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? Pseudophakia with PCO
? ARMD changes
? Other retinal pathologies
? Refractive error
66
NPDR, 62 PDR, 2
NAD, 336
TYPE OF RETINOPATHY
Type of Retinopathy No. of eyes Percentage
NPDR 62 15.5%
PDR 2 0.5%
NAD 336 84%
? In our study 62 eyes had non proliferative diabetic retinopathy.
? 2 patients  among the 400 had proliferative diabetic retinopathy
                  One patient had  NVD
                 Another patient had NVD with vitreous haemorrage.
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GRADING OF NPDR
Grading of NPDR No. of patients Percentage
Mild                    17 27.4%
Moderate                    38 61.3%
Severe                     5 8.1%
Very severe                     2 3.2%
Majority of the patients fall into the category of moderate NPDR.
27.4% of the patients had mild NPDR
Severe and very severe NPDR were also seen in very few
patients.
No. of patients
Mild
Moderate
Severe
Very severe
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MILD  NONPROLIFERATIVE  DIABETIC
RETINOPATHY   XL--1
MODERATE NONPROLIFERATIVE  DIABETIC
RETINOPATHY XL--169
SEVERE  NPDR     XL-28
PDR WITH VH    XL--152
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COMPLICATIONS
Complications No. of patients Percentage
VH 1 0.5%
RD - -
Iris neovascularisation - -
Of the diabetic retinopathy patients one patient had vitreous
haemorrage,  is one of the sight threatening complication seen in initial
presentation.
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Comparison of glycosylated hemoglobin level  in patients with and
without DR
Age group
Levels of
glycosylated
hemoglobin  in
patients with  DR
Levels of
glycosylated
hemoglobin   in
patients  without DR
30-40 years 7.2-8.0% 4.4-6.2%
41-50 years 7.8-9.4% 4.1-6.2%
51-60 years 6.9-9.9% 5.3-6.7%
The HbA1C levels of the patients with DR are higher than those
of the patients  without  retinopathy changes.
According to ADA  HbA1C levels more than 6.8% is considered
as poor glycaemic control.
So this indicates that patients might have had  poor glycaemic
control prior to the development of  DR.
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DISCUSSION
The aim of our study was to find the incidence of retinopathy
changes, in newly detected DM type II. 200 eyes of 100 patients
attending the ophthalmology outpatient department of the Stanley
Medical College, Hospital, Chennai were studied. Our observation were
compared with various other studies about diabetic retinopathy.
 Various studies performed in India as found that there is  an
increased prevalence of DR in type II DM in the past 30 yrs
          DR  prevalence  in  newly diagnosed  subjects in my study is16%
But it is comparatively  lower  than the prevalence data found in
Europe study which is 20% to 35% 38,39
The ratio of male to female patients in this study was 2.1:1 while
it was  1.5:1  in the Wisconian epidemiological study 40of DR 1984 and
1.8:1  in  the  Oman  study41  In  our  study  DR is more common in men
.
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Further studies  such as UKPDS study42, the Hyderabad study43,
and a study of Pima Indians44 also have concluded that DR is common
among males.
  DR prevalence  according to United Kingdom Prospective
Diabetes study (UKPDS),  at the time of initial  diagnosis was 35% but
the study subjects in UKPDS 42study are older than study subjects in this
study.
         In our study 12%  of patients had bilateral involvement, though
the severity was asymmetrical in some patients.4% of patients had
unilateral involvement.
Indirect  ophthalmoscopy  has been used  as a standard technique
in our study. The  sensitivity and specificity of  indirect ophthalmoscopy
for detecting any retinopathy was 82% and 95% respectively.
(Dandona et al)
The diabetes-associated changes in the trabeculum is related to
decreased  aqueous  outflow.  In  the Wisconsin  Epidemiologic study of
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Diabetic Retinopathy, approximately 8% of people with diabetes  in  the
older age group  had intraocular pressures greater than 21 mmHg. But
only  3% of nondiabetics in the older age group had IOP greater than 21
mmHg.45
There may be an effect of diabetes on the optic nerve. One can
postulate that the optic nerve of people with diabetes may be more
susceptible to destructive effects of intraocular pressure. This may
exacerbate an increased risk of glaucoma that accompanies aging.45
       Rema et al reported that 1.7-fold increase in risk of DR in subjects
with  2% increase in HbA1C.
      The  normal  range  for  the  hemoglobin  A1c   is  between  4%  and
5.6%. Hemoglobin A1c levels between 5.7% and 6.4% indicate
increased risk of diabetes, and levels of 6.5% or higher indicate diabetes.
In our study patients of DR had HbA1C level more than 7%,thus
indicates poor glycaemic control  previously.46
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The  important  risk factor  for diabetes is the blood HbA1c
levels. Wong et al reported  DR risk  increases 1-21-fold for every 1%
increase of HbA1C.  These observations were confirmed by our study
and have showed that a raised blood HbA1c concentration was
independently associated with an increased DR prevalence.
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SUMMARY
? 200 eyes of 100 patients were studied during the  period from
July 2010 to November 2012
? The predominantly affected group were between 40  to 50 years
of age(42.5%)
? The male:female ratio was 2.1:1
? A majority of patients had visual acuity between 6/9 and 6/18
on first presentation(43.5%)
? Of them 12% of patients had positive family history
? 33% of the patients were exposed to risk factors like smoking,
alcohol and anaemia.
? 12% 0f the patients had bilateral diabetic retinopathy
? Of the 200 eyes evaluated 62 eyes had NPDR and 2 had PDR
while 336 had no features of diabetic retinopathy.
? Among  the NPDR majority (38 eyes) fell under moderate
NPDR .
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?  Of the 100 patients 1 had VH at the time of persentation
? 3% of the patients had POAG during the initial presentation.
? Levels of glycosylated hemoglobin level (HbA1c)  were more
than 7mmol/l in patients with DR when compared to patients
without DR. This indicates patients would have had unnoticed
DM for a longer duration.
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CONCLUSION
? Incidence of DR is common among middle aged working
population.
? Both eyes were usually affected ,though asymmetrically.
? Detailed fundus examination and FFA  in selected cases are
important in diagnosing  the type and severity of diabetic
retinopathy.
? In conclusion DR associated  with vision  threatening
complications can be made out  even at the time of diagnosis
of diabetes mellitus type II.
? So regular ophthalmological evaluation  is necessary to detect
fundus changes  in early stages in new cases of DM type-2
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? Early diagnosis   and treatment of DR helps to stabilize the
visual acuity and prevent further loss.
? Diagnosis of complications of DR at the earliest helps to
control progression of PDR.
? Increased awareness of the ophthalmological complication in
diabetes is necessary in the society to prevent unnecessary
visual morbidity in diabetic patients.
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PROFORMA
INCIDENCE OF RETINOPATHY  CHANGES  IN PATIENTS
WITH  NEWLY  DETECTED   DIABETES   MELLITUS
 – a hospital based study
Hospital  no. :
Name :
Age :
Sex :
Occupation :
Address :
Ocular complaints :
Diabetic status
Type :
Treatment  details :
Family  history :
Associated  simultaneous
Systemic illness :
Associated Risk factors :
OCULAR EXAMINATION RE LE
Vision
       v/n  With pinhole
  BCVA
Eyelids and lashes
Extraocular movements
Slit lamp examination
Conjunctiva
Cornea
Anterior chamber
Iris
Pupil
Lens
IOP
Visual field
Gonioscopy
Fundus
a.Direct ophthalmoscopy
        1.media
       2.disc
                  Colour
                  Shape
                  Size
                Margins
              Cup
  3.vessels
              arteries
            Veins
4.Macula
                Foveal reflex
              Edema
1. Background of retina
b.Indirect ophthalmoscopy
Media
Disc
Macula
Periphery of retina
c.slit lamp examination+90D
INVESTIGATIONS
Bloodsugar
Fasting Post prandial
urine : Albumin
Sugar
Deposits
Blood  hemoglobin
Glycosylated hemoglobin
Blood urea
Serum creatinine
 KEY TO MASTER CHART
DM - Diabetes Mellitus
VA - Visual acuity
HM - Hand movements
CFCF - Counting fingers close to face
NPDR - Non-Proliferative diabetic retinopathy
PDR - Proliferative diabetic retinopathy
MILD NPDR - Mild  Non-Proliferative diabetic retinopathy
Mod NPDR - Moderate Non-Proliferative diabetic
retinopathy
Sev NPDR - Severe Non-Proliferative diabetic
retinopathy
VS NPDR - Very Severe Non-Proliferative diabetic
retinopathy
BCVA - Best corrected visual acuity
IOP - Intra ocular pressure
M - Male
F - Female
A - anemia
AL - Alcoholism
S - Smoking
FBS - Fasting Blood Sugar
PPBS - Post Prandial Blood Sugar
HBA1C - Glyco sylated Hb
RE - Right Eye
LE - Left Eye
PRP - Pan-retinal photocoagulation
I - Insulin
O - Oral hypoglycemic agents
Comp. - Complications
VH - Vitreous hemorrhage
RD - Retinal detachment
CRAO - Central retinal Artery occlusion
Hosp No. - Hospital Number
RE LE RE LE FBS PPBS RE LE RE LE
1 Rathinam 55 M 171986 6/18 6/12 6/9 6/9 - S+AL+A 166 273 8.3 12 O - Mild NPDR - - -
2 Sulochana 33 F 298764 6/12 6/6 6/6 6/6 - - 179 232 4.5 14 O - - - - -
3 Boopalan 41 M 193279 6/9 6/9 6/6 6/6 - - 181 297 4.7 11 O - - - - -
4 Ranganathan 44 M 397641 6/6 6/6 6/6 6/6 - - 176 320 5.4 10 O - - - - -
5 Soundappan 38 M 316348 6/12 6/6 6/6 6/6 S+AL 187 234 5.7 14 O - - - - -
6 Ramesh 43 M 493817 6/24 6/12 6/12 6/12 + S 182 271 5.2 16 O - - - - -
7 Albert 43 M 293798 6/12 6/24 6/6 6/12 - AL 176 274 5.3 17 O - - - - -
8 Rani 45 F 1843217 6/6 6/6 6/6 6/6 - - 157 257 4.6 15 O - - - - -
9 Manickam 32 M 304678 6/6 6/6 6/6 6/6 - - 156 280 4.7 12 O - - - - -
10 Marimuttu 58 M 329781 6/36 6/60 6/24 6/12 - S+AL+A 210 326 8.8 16 O MOd NPDR MOd NPDR - - -
11 Baby 49 F 193671 6/9 6/18 6/6 6/6 - - 186 271 5.7 18 O - - - - -
12 Panneerselvam 31 M 274136 6/12 6/6 6/6 6/6 - S+AL 173 312 6.2 13 O - - - - -
13 Babu 47 M 381376 6/12 6/12 6/6 6/6 - AL 186 321 5.6 12 O - - - - -
14 Shanthi 51 F 281979 6/18 6/18 6/18 6/9 - 271 391 7.9 13 I+O - Mild NPDR - - -
15 Periasamy 48 M 314625 6/24 6/36 6/6 6/12 + S+AL+A 181 392 8.2 23 O MOd NPDR MOd NPDR - - -
16 Angamuttu 46 M 1311271 6/6 6/6 6/6 6/6 - S+AL 189 272 4.6 14 O - - - - -
17 Harikrishnan 48 M 179648 6/9 6/6 6/6 6/6 - S 168 211 5.7 12 O - - - - -
18 Arumugam 35 M 134679 6/12 6/12 6/6 6/6 - AL 176 267 5.7 17 O - - - - -
19 Shanthi 33 F 117911 6/12 6/12 6/6 6/6 - - 210 382 5.8 16 O - - - - -
20 Kumar 53 M 139798 6/18 6/36 6/12 6/18 - S+AL+A 182 293 8.5 24 O MOd NPDR MOd NPDR - - -
21 Suresh 33 M 396178 6/18 6/6 6/6 6/6 - - 192 317 5.3 13 O - - - - -
22 Kumaresan 42 M 346819 6/6 6/12 6/6 6/6 - - 182 265 4.9 12 O - - - - -
23 Sundari 51 F 224221 6/9 6/6 6/6 6/6 - - 210 352 4.3 10 O - - - - -
24 Vasanthakumar 35 M 297618 6/6 6/9 6/6 6/6 - - 171 351 5.9 12 O - - - - -
25 Dhanakotti 43 M 391622 6/36 6/60 6/24 6/24 - S+AL+A 187 324 9.3 28 O Sev NPDR MOd NPDR - - -
26 Peter 51 M 317986 6/18 6/12 6/9 6/9 - AL 171 259 6.3 16 O - - - - -
27 Gomathy 45 F 334678 6/36 6/36 6/9 6/9 - A 199 376 8.3 18 O Mod NPDR Mod NPDR - - -
28 Mariammal 39 F 331789 6/36 6/24 6/12 6/9 - A 232 397 9.1 12 O Sev NPDR MOd NPDR - - -
29 Purusothaman 44 M 131146 6/12 6/6 6/6 6/6 - - 176 267 6.2 13 O - - - - -
30 Prabaharan 42 M 291744 6/6 6/6 6/6 6/6 - S 186 245 5.6 12 O - - - - -
31 Doulath 44 F 146891 6/6 6/6 6/6 6/6 - - 171 286 4.5 15 O - - - - -
32 Karthick 44 M 246894 6/12 6/12 6/6 6/6 - - 186 290 5.8 12 O - - - - -
33 Aruldurai 43 M 241316 6/12 6/6 6/6 6/6 - - 162 311 4.6 14 O - - - - -
34 Shanker 39 M 413746 6/18 6/12 6/6 6/6 - - 177 287 4.8 14 O - - - - -
35 Mani 45 M 241763 6/24 6/18 6/9 6/6 - - 210 326 5.3 13 O - - - - -
36 Hafesa 42 F 196913 6/24 6/24 6/12 6/12 - - 186 271 4.6 13 O - - - - -
37 Karthikeyan 39 M 148919 6/12 6/6 6/6 6/6 - - 173 265 5.7 11 O - - - - -
38 Settumani 51 F 393716 6/24 6/18 6/6 6/12 - S+AL+A 186 345 5.7 16 O - Mild NPDR - - -
39 Rathinam 35 M 137819 6/6 6/18 6/6 6/6 - - 210 298 4.9 16 I+O -          - - - -
40 Paavendhan 46 M 234532 6/12 6/36 6/9 6/12 + A 181 290 5,8 17 O - - - - -
41 Ayesha 53 F 347619 6/6 6/6 6/6 6/6 - - 189 272 5.3 16 O - - - - -
42 Mokamed 43 M 413761 6/6 6/6 6/6 6/6 - AL 168 321 5.7 16 O - - - - -
43 Ambiga 34 F 341318 6/12 6/12 6/6 6/6 - - 201 289 4.7 18 O - - - - -
44 Duraisamy 51 M 343719 6/12 6/12 6/12 6/9 - - 210 382 4.6 13 O - - - - -
45 Raman 41 M 331719 6/12 6/18 6/6 6/12 + S+AL+A 233 389 8.3 12 O Mild NPDR Mild NPDR - - -
46 Paranjothi 42 M 346798 6/18 6/6 6/6 6/6 - - 192 317 5.5 13 O - - - - -
47 Rekha 54 F 194624 6/6 6/6 6/6 6/6 - - 182 271 6.2 12 O - - - - -
48 Rajamani 44 M 317323 6/9 6/6 6/6 6/6 - - 210 352 5.7 12 O - - - - -
49 Baskhar 46 M 197211 6/6 6/18 6/6 6/6 - - 171 351 6.2 15 O - - - - -
50 Vijayalakhsmi 32 F 193798 6/6 6/6 6/6 6/6 - - 165 218 5.8 17 0 - - - - -
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51 Vinoth 51 M 467198 6/6 6/6 6/6 6/6 - S 198 273 6 12 O - - - - -
52 Ammarng 31 M 314462 6/12 6/6 6/6 6/6 - - 179 301 5.8 14 O - - - - -
53 Paramanadhan 48 M 343627 6/8 6/9 6/6 6/6 - - 181 252 4.8 13 O - - - - -
54 Narajanan 51 M 481769 6/24 6/24 6/6 6/18 - S+AL+A 176 320 9 11 O MOD NPDR MOD NPDR - - -
55 Indhumathi 56 F 346178 6/12 6/12 6/6 6/6 - - 176 298 5.2 18 O - - - - -
56 Francis 37 M 481796 6/6 6/6 6/6 6/6 - AL 182 271 5.8 16 O - - - - -
57 Priya 41 F 461789 6/6 6/6 6/6 6/6 - 126 274 4.9 13 O - - - - -
58 Amalya 43 F 294672 6/6 6/6 6/6 6/6 - - 157 257 4.7 12 O - - - - -
59 Jayakumar 32 M 413798 6/6 6/6 6/6 6/6 - - 191 280 5.9 12 O - - - - -
60 mohamed basha 54 M 331122 6/18 6/24 6/9 6/12 - S+AL+A 210 326 7.3 17 O MOd NPDR Mild NPDR - - -
61 Antony 41 M 346917 6/6 6/6 6/6 6/6 - - 186 271 4.7 15 O - - - - -
62 Gangadharan 43 M 176922 6/12 6/6 6/6 6/6 - - 173 312 5.7 15 O - - - - -
63 Kannan 34 M 176413 6/12 6/9 6/6 6/6 - S 186 321 6.2 14 O - - - - -
64 Sarala 59 F 343516 6/60 6/60 6/18 6/24 - S+AL+A 271 391 8.1 12 I+O Mild NPDR MOD NPDR - - -
65 Babu 45 M 313768 6/12 6/36 6/61 6/12 + - 181 392 6 17 O - - - - -
66 Joyal 47 M 345136 6/6 6/6 6/6 6/6 - AL 189 272 6.2 17 O - - - - -
67 Shanmugam 36 M 293176 6/9 6/6 6/9 6/6 - S 176 321 5.2 15 O - - - - -
68 Kamatchi 43 F 379198 6/12 6/12 6/6 6/6 - - 209 327 5.9 24 O - - - - -
69 Backiaraj 49 M 413748 6/12 6/12 6/6 6/6 - - 179 256 5.7 12 O - - - - -
70 Karuppusamy 37 M 413398 6/6 6/6 6/6 6/6 - - 182 293 4.9 17 O - - - - -
71 Karpagam 56 F 371642 6/18 6/12 6/12 6/6 - - 192 317 4.2 14 O - - - - -
72 Senthilkuar 42 M 241796 6/6 6/6 6/6 6/6 - - 182 271 5.9 12 O - - - - -
73 Santhosten 39 M 314464 6/9 6/6 6/6 6/6 - - 210 352 4.8 12 O - - - - -
74 Abirami 44 F 221318 6/6 6/24 6/6 6/6 - - 171 351 4.5 17 O - - - - -
75 Bharathi 42 M 413299 6/18 6/6 6/9 6/6 - - 187 231 6.1 15 O - - - - -
76 Velmurugan 42 M 416738 6/6 6/6 6/6 6/6 - S 121 273 5.9 16 O - - - - -
77 Duraisamy 32 M 393176 6/12 6/6 6/6 6/6 - - 179 301 5.7 14 O - - - - -
78 Ranganathan 43 M 391798 6/18 6/9 6/9 6/6 - S+AL+A 181 252 .6.2 13 O MOD NPDR - - - -
79 Shanmugam 54 M 221468 6/6 6/6 6/6 6/6 - - 176 320 5.7 14 O - - - - -
80 Chandrakumar 45 M 416978 6/12 6/12 6/6 6/6 - S+AL 216 321 5.3 12 O - - - - -
81 Roopa 47 F 3910608 6/24 6/6 6/12 6/6 - - 182 271 4.6 15 O - - - - -
82 Srinivasan 34 M 381368 6/9 6/6 6/6 6/6 - S 126 274 5.7 14 O - - - - -
83 Murali 53 M 241736 6/6 6/6 6/6 6/6 - - 157 257 6.1 17 O - - - - -
84 Muthukumar 48 M 468321 6/6 6/6 6/6 6/6 - S+AL 191 280 5.8 15 O - - - - -
85 Ruckmani 35 F 134591 6/18 6/6 6/9 6/6 - - 210 326 4.9 12 O - - - - -
86 Munusamy 52 M 241398 6/6 6/6 6/6 6/6 - - 186 271 4.8 12 O - - - - -
87 Ambaranath 31 M 460312 6/12 6/6 6/6 6/6 - - 173 312 5.7 14 O - - - - -
88 Annamal 48 F 221468 6/24 6/24 6/9 6/12 - - 186 321 6.4 13 O - - - - -
89 Ramu 42 M 440801 6/6 6/12 6/6 6/6 - S+AL+A 271 391 8.3 16 I+O - Mild NPDR - - -
90 Vasantha 39 F 135791 6/12 6/6 6/6 6/6 - 181 392 6.2 14 O - - - - -
91 Narayan 52 M 217698 6/36 6/18 6/36 6/12 - S 189 272 5.7 12 O - - - - -
92 Ruckmani 32 F 327168 6/6 6/6 6/6 6/6 - - 252 194 6.2 13 O - - - - -
93 Selvarangam 51 M 281719 6/60 6/36 6/12 6/18 - S+AL+A 281 401 7.4 16 O+I MOD NPDR SEV NPDR - - -
94 Gonndan 45 M 394672 6/12 6/12 6/6 6/6 - S+AL 210 382 4.9 12 O - - - - -
95 Gajalanathan 34 M 161982 6/6 6/6 6/6 6/6 - - 182 293 5.7 13 O - - - - -
96 sathya 54 F 143172 6/18 6/6 6/6 6/6 - - 192 317 4.3 17 O - - - - -
97 Mathew 47 M 169321 6/6 6/12 6/6 6/6 - - 182 271 5.4 13 O - - - - -
98 Ilayaraja 54 M 297861 6/9 6/6 6/6 6/6 - S 210 352 6.3 15 O - - - - -
99 Shajagan 49 M 314678 6/6 6/18 6/6 6/6 - - 171 351 5.8 16 O - - - - -
100 Rangan 35 M 413268 6/6 6/6 6/6 6/6 - - 176 235 5.5 15 O - - - - -
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101 Sugam 37 M 346897 6/6 6/6 6/6 6/6 - AL 121 273 6.4 12 O - - - - -
102 poomalai 46 M 194642 6/12 6/24 6/6 6/12 - S+AL+A 179 301 8.2 17 O MOD NPDR MOD NPDR - - -
103 Murugan 35 M 317233 6/8 6/9 6/6 6/6 - - 181 252 6.1 11 O - - - - -
104 muttu 38 M 197112 6/6 6/6 6/6 6/6 - - 176 320 5.6 10 O - - - - -
105 laksmi 45 F 467981 6/12 6/12 6/6 6/6 - - 216 181 6 13 O - - - - -
106 prabha 49 F 314462 6/24 6/6 6/12 6/6 - -41066 182 271 5.7 16 O - - - - -
107 kumar 51 M 313276 6/3 6/6 6/6 6/6 - S 146 274 8 12 O - - - - -
108 Kumari 34 F 481697 6/6 6/6 6/6 6/6 - - 157 285 5 17 O - - - - -
109 Sugavanam 38 M 461897 6/6 6/6 6/6 6/6 - - 191 280 5.5 14 O - - - - -
110 Arya 44 F 461894 6/18 6/6 6/9 6/6 - A 210 326 4.7 12 O - - - - -
111 Yoshwa 47 M 294726 6/6 6/6 6/6 6/6 - - 186 271 5.4 12 O - - - - -
112 Mohamed 36 M 413789 6/12 6/6 6/6 6/6 - - 173 312 6.2 14 O - - - - -
113 vasanthan 50 M 331212 6/12 6/12 6/12 6/9 - S 186 321 5.7 12 O - - - - -
114 Vimala 45 F 563248 6/9 6/12 6/6 6/6 - - 271 391 8 15 I+O Mild NPDR - - - -
115 Biman 54 M 179486 6/12 6/36 6/9 6/12 + - 181 392 5 13 I+O - - - - -
116 Samy 59 M 134196 6/24 6/18 6/12 6/12 - S 176 272 7.3 12 O Mild NPDR MOD NPDR - - -
117 Umadevi 60 F 119711 6/24 6/18 6/12 6/12 - - 189 270 5.8 10 O - - - - -
118 Banu 57 F 139981 6/12 6/12 6/6 6/6 - S+AL+A 281 401 7.9 13 O+I Mild NPDR MOD NPDR - - -
119 Nisha 43 F 396213 6/12 6/12 6/6 6/6 - - 210 382 6.2 12 O - - - - -
120 Sampath 51 M 224223 6/6 6/60 6/36 6/6 - - 182 293 5.7 13 O - - - - -
121 Kumaran 32 M 297867 6/18 6/6 6/6 6/6 - - 192 317 6.2 11 O - - - - -
122 Muskan 37 M 334891 6/6 6/12 6/6 6/6 - - 182 271 5.9 13 O - - - - -
123 sathyan 54 M 131156 6/9 6/6 6/6 6/6 - - 210 352 5.3 13 O - - - - -
124 Pavadairayan 53 M 291766 6/6 6/18 6/6 6/6 - - 171 351 4.7 14 O - - - - -
125 Eswar 39 M 171879 6/6 6/6 6/6 6/6 - - 187 233 6.2 11 o - - - - -
126 Muneeswari 44 F 298647 6/6 6/9 6/6 6/6 - A 121 273 5.7 10 O - - - - -
127 kulandai 48 M 193771 6/24 6/24 6/6 6/6 - - 179 301 6.3 14 O - - S - -
128 manonmani 55 F 397146 6/18 6/9 6/9 6/6 - - 181 252 5.6 12 O - - - - -
129 Thangaraj 32 M 316483 6/6 6/6 6/6 6/6 - S 176 320 5.3 12 O - - - - -
130 Samikkanu 32 M 493176 6/12 6/12 6/6 6/6 - - 167 212 5.6 13 O - - - - -
131 Thomas 34 M 293908 6/24 6/6 6/12 6/6 - S 182 271 5.7 17 O - - - - -
132 Md.ibraheem 37 M 184123 6/12 6/6 6/6 6/6 - S+AL+A 189 274 7.1 13 O Mild NPDR - - - -
133 Saraswathy 45 F 304781 6/6 6/6 6/6 6/6 - - 157 257 6.1 12 O - - - - -
134 Ayyavu 35 M 329678 6/6 6/6 6/6 6/6 - - 191 280 5.6 10 O - - - - -
135 Mari 39 M 274381 6/12 6/6 6/9 6/6 - - 210 326 4.6 13 O - - - - -
136 Eswari 54 F 381234 6/18 6/24 6/12 6/12 - - 186 271 6.1 11 O - - - - -
137 Ponnan 57 M 281999 6/60 6/60 6/36 6/36 - S+AL+A 254 412 8.3 26 O+I Sev NPDR V SEV NPDR - - -
138 Elango 43 M 314111 6/12 6/24 6/6 6/6 - S 186 321 5.6 12 O - - - - -
139 Prabaharan 44 M 416321 6/12 6/18 6/6 6/6 - - 271 391 4.7 13 I+O - - - - -
140 Kaliappan 51 M 393178 6/12 6/36 6/12 6/12 + S+AL+A 181 392 7.3 14 O MOD NPDR MOD NPDR - - -
141 Kalyani 57 F 416415 6/6 6/6 6/6 6/6 - - 189 272 6.1 12 O - - - - -
142 Antony 43 M 221546 6/9 6/6 6/6 6/6 - S 252 354 5.8 11 O - - - - -
143 Govindasamy 42 M 391768 6/12 6/12 6/6 6/6 - - 281 401 6.2 10 O - - - - -
144 Santhi 54 F 381441 6/12 6/12 6/6 6/6 - - 210 382 5.7 12 O - - - - -
145 Banu bagam 42 F 241778 6/6 6/6 6/6 6/6 - A 182 293 6 11 O - - - - -
146 Ismail 33 M 132663 6/18 6/6 6/6 6/6 - - 192 317 6.2 13 O - - - - -
147 Rose mary 45 F 460991 6/6 6/12 6/6 6/6 - - 182 271 4.9 15 O - - - - -
148 Mumtaz 55 F 135896 6/12 6/9 6/12 6/6 - - 210 352 6 13 O - - - - -
149 Saravanan 59 M 346231 6/36 6/18 6/6 6/6 - - 171 351 5.3 16 O - - - - -
150 Nandakumar 57 M 176090 6/24 6/18 6/6 6/9 - S+AL+A 187 289 8.5 12 O MOD NPDR MOD NPDR - - -
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151 Perumal 55 M 413422 6/12 6/9 6/6 6/6 - S 121 273 5.7 `4 O - - - - -
152 Meenatchi 57 F 224401 6/36 6/36 6/18 6/12 - S+AL+A 243 402 9 11 O+I PDR V SEV NPDR - VH -
153 Athi 58 M 371980 6/8 6/9 6/6 6/6 - - 181 252 5,1 13 O - - - - -
154 Thambidurai 51 M 293376 6/12 6/18 6/9 6/12 - S+AL+A 176 320 9.9 16 O Mild NPDR MOD NPDR - - -
155 Appasamy 35 M 413370 6/12 6/12 6/6 6/6 #VALUE! - 176 231 6.2 12 O - - - - -
156 Narayanan 36 M 345056 6/24 6/24 6/12 6/6 + S 182 271 4.7 12 O - - - - -
157 Muttu naicker 33 M 314646 6/6 6/9 6/6 6/6 - S 126 274 5.7 14 O - - - - -
158 Asaithambi 30 M 217167 6/6 6/6 6/6 6/6 - - 157 257 4.8 11 O - - - - -
159 Chinnusamy 52 M 327897 6/36 6/24 6/6 6/6 - - 191 280 5.2 12 O - - - - -
160 Anguraj 45 M 169056 6/18 6/6 6/9 6/6 - - 210 326 5 14 O - - - - -
161 Brintha 43 F 413551 6/6 6/6 6/6 6/6 - - 186 271 5.3 12 O - - - - -
162 Kalaiarasan 49 M 314118 6/12 6/6 6/6 6/6 - - 173 312 5.2 12 O - - - - -
163 Lila 46 F 314736 6/12 6/18 6/6 6/6P - S 186 321 5 11 O - - - - -
164 Devikarani 48 F 413363 6/6 6/24 6/6 6/24 - A 271 391 8.6 15 I+O Mild NPDR Mod NPDR - - -
165 Subramani 44 M 224890 6/12 6/36 6/18 6/12 + S+AL+A 181 392 9 16 O+I MOD NPDR MOD NPDR - - -
166 Siva 47 M 413098 6/9 6/6 6/6 6/6 - S 189 272 5.7 12 O - - - - -
167 Mohan 30 M 101546 6/9 6/6 6/6 6/6 - S 176 243 6.2 15 O - - - - -
168 Arumugam 36 M 297432 6/6 6/6 6/6 6/6 - S 169 234 5.6 17 O - - - - -
169 Kumari 57 F 281734 6/24 6/36 6/12 6/18 - - 189 382 7.4 13 O MOD NPDR Mild NPDR - - -
170 Kaleesswari 42 F 314110 6/6 6/6 6/6 6/6 - - 182 293 6.6 15 O+I - - - - -
171 Steepan 34 M 373764 6/18 6/6 6/6 6/6 - - 187 244 5.8 16 O - - - - -
172 Indu 35 F 478493 6/6 6/12 6/6 6/6 - - 182 271 4.5 13 O - - - - -
173 Anandan 41 M 263756 6/9 6/6 6/6 6/6 - S+AL+A 210 352 7.9 13 O+I MOD NPDR MOD NPDR - - -
174 Kaliammal 44 F 108765 6/6 6/18 6/6 6/6 - - 171 351 5.P0 11 O - - - - -
175 Ramanan 45 M 276548 6/18 6/12p 6/6 6/6 - - 176 243 4.9 16 O - - - - -
176 Pavalakodi 39 F 345743 6/9 6/12 6/6 6/6 121 273 5.7 15 O - - - - -
177 Backiam 47 F 432598 6/24 6/12 6/6 6/6 - - 179 301 8.3 12 O Mild NPDR Mild NPDR - - -
178 Pappathy 49 F 112657 6/18 6/9 6/6 6/6 - - 181 252 6.3 13 O - - - - -
179 Nazeera 39 F 143268 6/6 6/6 6/6 6/6 - - 176 241 5.9 13 O - - - - -
180 vivekandan 37 M 232122 6/6 6/6 6/6 6/6 - - 176 233 6.1 18 O - - - - -
181 Moorthy 52 M 134543 6/24 6/6 6/12 6/6 + S 211 398 7.4 14 O MOD NPDR PDR - - -
182 Manikandan 36 M 432564 6/18 6/12 6/6 6/6 - S+AL 126 274 5 13 O - - - - -
183 Sankaran 39 M 234323 6/6 6/6 6/6 6/6 - - 157 257 5.6 11 O - - - - -
184 Rangan 42 M 345434 6/6 6/6 6/6 6/6 - - 191 280 5.6 12 O - - - - -
185 Ramu 31 M 111123 6/18 6/6 6/6 6/6 - S+AL+A 210 326 8.5 15 O Mild NPDR Mild NPDR - - -
186 Vaithiyalingam 42 M 234323 6/6 6/6 6/6 6/6 - - 186 271 4 12 O - - - - -
187 Madurai veeran 47 M 237654 6/12 6/9 6/6 6/6 - - 173 293 4.4 17 O - - - - -
188 Pushpa 36 F 345362 6/12 6/6 6/6 6/6 - - 186 321 5.6 13 O - - - - -
189 Radha 37 F 342568 6/6 6/12 6/6 6/6 - A 271 391 7.9 13 I+O Mild NPDR MOD NPDR - - -
190 Kannayeram 40 M 110023 6/24 6/36 6/12 6/12 + S+AL+A 181 392 8.8 26 O+I Sev NPDR MOD NPDR - - -
191 Rani 49 M 118790 6/60 6/24 6/6 6/6 - S 189 272 5.5 11 O - - - - -
192 Selvam 58 M 436271 6/9 6/6 6/6 6/6 - S 252 194 4.7 10 O - - - - -
193 Senthilkuar 57 M 364758 6/12 6/12 6/6 6/6 - S 281 401 4.8 15 O - - - - -
194 Ravi 60 M 234323 6/12 6/12 6/6 6/6 - - 198 382 5.3 15 O - - - - -
195 Kulandaisamy 42 M 112321 6/6 6/9 6/6 6/6 - S+AL 182 293 6 17 O - - - - -
196 Narayanasamy 45 M 342564 6/18 6/6 6/6 6/6 - S+AL 192 317 5.2 12 O - - - - -
197 Raman 53 M 543627 6/12 6/12 6/6 6/6 - S+AL 187 271 5.3 15 O - - - - -
198 Boopalan 35 M 234376 6/9 6/6 6/6 6/6 - - 175 245 4.6 12 O - - - - -
199 Arasappan 42 M 112232 6/6 6/18 6/6 6/6 - S 171 245 5.6 10 O - - - - -
200 Kalian 41 M 324563 6/12 6/12 6/9 6/12 - S+AL+A 186 343 8.3 13 O MOD NPDR MOD NPDR - - -
TREATMENT
OF DM
DIAGNOSIS MACULOPATHY COMPLICATIO
NS
V/A ON PRESENTATION BCVA FAMILY
HISTROY
ASSOCIATED
RISK FACTORS
BLOOD SUGAR
SNO NAME AGE SEX Hospital No.
